63 results
8-K
EX-10.1
ATXG
Addentax Group Corp
29 Apr 24
Addentax Group Corp. Announces Private Placements of its Common Stock
11:50am
or in the aggregate, a Material Adverse Effect. For the purpose of this Agreement, “Material Adverse Effect” means (i) any material adverse effect
8-K
EX-10.2
ATXG
Addentax Group Corp
29 Apr 24
Addentax Group Corp. Announces Private Placements of its Common Stock
11:50am
or in the aggregate, a Material Adverse Effect. For the purpose of this Agreement, “Material Adverse Effect” means (i) any material adverse effect
8-K
EX-10.1
ATXG
Addentax Group Corp
29 Apr 24
Departure of Directors or Certain Officers
9:30am
may be in doubt, please discuss this with our corporate counsel. For the purpose of clarity, under the Nasdaq listing rules, an independent director
8-K
6biiu2x
2 Sep 22
Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $25 Million Public Offering of Common Stock
11:13am
8-K
EX-4.1
epzt5hp2
2 Sep 22
Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $25 Million Public Offering of Common Stock
11:13am
8-K
EX-1.1
x11lwzaoy2osr38dg
2 Sep 22
Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $25 Million Public Offering of Common Stock
11:13am
424B4
dok1b40 7vmjnv1bcse
31 Aug 22
Prospectus supplement with pricing info
6:12pm